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Summary
Objective: Myoclonic epilepsy is a common epileptic syndrome with high genetic
contribution. We described a pedigree in which 10 individuals presented with a non-
progressive, adult-onset myoclonic epilepsy.
Materials and methods: The pedigree was constructed and analyzed. Six affected
members were studied with clinical grounds, mental status, neurophysiology,
video-electroencephalographic (EEG), brain magnetic resonance imaging (MRI) and
mutational analysis of GABRA1 (GABRA1A, which endoces the a1 subunit of the g-
aminobutyric acid receptor subtype A). Clinical and EEG data were collected from six
unaffected members.
Results: Autosomal dominant hereditary was shown. The age of seizure onset was
approximately 40. All the individuals had myoclonic seizures and a normal cognitive
level. Bilateral symmetric jerks of the shoulders, arms or legs featured the myoclonic
seizure. Ictally, the consciousness was not affected. The ictal EEG demonstrated
bilateral spikes-and-waves. The occurrence of myoclonic seizures was not associated
with sleepiness. Rare generalized tonic-clonic seizures occurred in two individuals. No
absence or accompanying involuntary movements were observed. A lower dose of
valproic acid (200—500 mg/D) (clonazepam 0.5 mg/D in a patient) was required to
stop the myoclonic seizures.
Conclusions: The clinical features of late adult-onset autosomal dominant myoclonic
epilepsy are similar to juvenile myoclonic epilepsy (JME), which is a common general-
ized epileptic syndrome with a significant hereditary component. But the age of
* Corresponding author at: Department of Neurosurgery, Buddhist Tzu Chi General Hospital, 707, Chung Yang Road, Sec. 3, Hualien 970,
Taiwan. Tel.: +886 3 8561825; fax: +886 3 8577161.
E-mail address: nsha@tzuchi.com.tw (T. Harnod).
1059-1311/$ — see front matter # 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.seizure.2006.11.006
Adult-onset autosomal dominant myoclonic epilepsy 161
onset, rare association of other seizure patterns, and non-relation of seizure onset to
sleepiness suggest that this may be a distinct familial epileptic syndrome different
from recognized familial myoclonic epilepsies.
# 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Many epileptic syndromes, currently recognized by
the International League Against Epilepsy (ILAE),
fit the original operational definition of idiopathic
generalized epilepsy (IGE) syndrome.1,2 These IGE
syndromes, which can affect children, adoles-
cents, and young adults, exhibit some overlap:
absence, myoclonic seizures, and tonic-clonic sei-
zures, and the electroencephalographic (EEG) hall-
mark of paroxysms of generalized spike-wave.
Recent studies reported that onset after the age
of 20 years is not rare.3,4 Familiarity often shows in
those patients with adult-onset generalized sei-
zure with myoclonus, myoclonic epilepsy, or both.
A mutation of the a-1 subunit of the g-aminobu-
tyric acid receptor (GABRA1) has been firstly
found in a French-Canadian family with autosomal
dominant heredity of a phenotype consistent with
juvenile myoclonic epilepsy (JME), a common IGE
syndrome.5
In 2002, we found four members of an East-
Taiwanese aboriginal family with epilepsy. Until
2006, 10 affected family members have had a
similar phenotype. The affected members experi-
enced myoclonic jerks that began in their 30s and
40s. We studied the clinical features, brain struc-
ture, intelligence, electroencephalographic activ-
ity and neurophysiology of the members with or
without myoclonic jerks. We also analyzed the
sequence of GABRA1, and attempted to identify
specific clinical and EEG features of the epileptic
syndrome. In this study, we aimed to classify
and report the familial myoclonic epilepsy, a syn-
drome or a seizure subtype that may be not
recognized.Figure 1 The pedigree of East-Taiwanese aboriginal kindred
dominant inheritance pattern. The age of the oldest fourth gMaterials and methods
The proband (II-5) of a family from Hualien, East
Taiwan, a 50-year-old man, was referred to our
epilepsy center for seizure treatment. This male
patient had a substantial family history positive
for myoclonic jerks. A detailed family pedigree
was constructed by collecting clinical histories on
all affected and unaffected individuals and their
spouses. There were 10 affected members (of whom
9 are alive) over four generations. We obtained
genealogical information on 63 family members
(including 16 spouses), and conducted an evaluation
of 12 individuals (Fig. 1). All study participants were
provided informed consent.
Blood samples were collected from 11 members
(including patients II-1, II-3, II-4, II-5, III-3, and III-
10) after informed written consent. Genomic DNA
was extracted using standard techniques from per-
ipheral blood leukocytes. Sequence analysis of
GABRA1 was amplified from genomic DNA using
intronic primers 50TGCCATTCCATGAATCACAG30 and
50TCATGGCACTTAATTGTTTACG30. The sequence
of each amplicon was confirmed by sequencing in
both directions. Sequences were compared with
the reference GABRA1 mRNA sequence (GenBank
NM_000806).
Long-term video-EEG monitoring with a standard
International 10-20 system setting was performed
on six affected individuals (patients II-1, II-3, II-4, II-
5, III-3, and III-10). An EEG recording that included
sleep was also performed on five clinically unaf-
fected individuals. The recording included hyper-
ventilation and photic stimulation. Somatosensory
evoked potentials (SEPs) were recorded from cen-
troparietal (C30, C40 = 2 cm behind the Internationalaffected with myoclonic epilepsy suggests an autosomal
eneration member is 27 years.
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cervical level, and from Erb’s point, using referen-
tial montages. Median nerve stimulation (0.2 ms
pulse width with four pulses per second in 500 trials)
was performed on four affected individuals
(patients II-1, II-3, III-3, and III-10).
We examined the intellectual abilities on five
affected individuals (patients II-1, II-3, II-4, II-5,
and III-10) with the administration of the Wechsler
Adult Intelligence Scale-III (Chinese version). Each
affected family member underwent brain magnetic
resonance imaging (MRI) with 1.5 T instrumentation
(axial T2-fluid-attenuated inversion recovery
(FLAIR), axial spoiled gradient recalled echo (SPGR),
axial diffusion tensor MRI (DTI), and sagital T1).Results
Ten members of the affected family (six men and
four women, including the first generation) experi-
enced myoclonic seizures. An autosomal dominant
inheritance pattern with high penetration was
observed (Fig. 1). The age of onset of the affected
individuals ranged from 35 to 42 years. The age of
the oldest fourth generation member was 27 years.
No similar symptom or presentation of febrile
convulsion was observed in the fourth generation
members. In second and third generation
family members, no febrile seizure or a history ofFigure 2 The ictal EEGs from patients II-1, II-convulsion were reported prior to myoclonic seizure
development.
In the affected family members, the myoclonic
jerks usually occurred as a single episode through-
out the day. On average, the frequency of mylco-
nic seizures was once daily, and the seizure might
be associated with a fall. There usually was no
obvious alternation of consciousness. The affected
family members could not ascertain whether or
not the myoclonic jerks occurred during sleep.
Alcohol or menstruation did not affect the number
of seizures. Fatigue tended to increase the num-
ber of myoclonic jerks experienced by the
patients. However, the jerks did not group into
a cluster. Typically, the myoclonic seizures were
characterized by bilateral symmetric involvement
of the shoulders and limbs, and were not asso-
ciated with noticeable changes in consciousness. If
the myoclonic jerk affected the lower extremi-
ties, hyperextension of the legs led to an unpre-
dicted slump. (This was the experience of patients
II-1, II-3, and II-5.) On neurological examination,
no neurological deficit was identified and no
movement disorders, such as choreoathetosis or
astasis, were observed.
Five myoclonic seizures (three seizures in patient
II-1 during light sleep, early morning, and daytime,
respectively; one seizure in patient II-3 in the early
morning; and one seizure in patient III-3 during the
daytime) were recorded. The seizure onset was in3, and III-3 show bilateral spike-and-waves.
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spike-and-wave complexes (Fig. 2). In the long-term
EEG recordings, bilateral synchronous spike/poly-
spike-and-waves appeared in all behavior states
including the slow-wave- and REM-sleep stages (in
patients II-1, II-3, and II-5). The epileptiform activ-
ity was not shown in the standard EEG registrations
of non-affected members. Photic stimulation did
not provoke EEG responses in the six patients and
six non-affected members.
Sequence alignments and comparisons with the
wild-type sequence (GenBank NM_000806) did not
indicate any deletion or point mutation. The
GABRA1 Ala322Asp mutation was not observed in
any sampledmember. Full scale IQ ranged from 90 to
104 in the five patients submitted to the entire
scale. No figure for the performance IQ was greater
or lesser than the verbal IQ was shown. The
SEP studies did not show increased amplitude
or prolonged latency of scalp potential amplitude.
The brain MRI scans did not depict any structural
disorder.
A low dose of valproic acid (range, 200—500 mg
per day) was required to stop the myoclonic sei-
zures. Themyoclonic seizures relapsed within 2 days
after drug discontinuation. This occurred despite
the fact that patients II-1 and II-3 were seizure free
for a 2-year period. Intrafamilial variation was lim-
ited. Two probands (patients II-3 and II-4) experi-
enced rare generalized tonic-clonic convulsions
(GTC). The GTCs did not recur since the valproic
acid was administrated (Table 1).Table 1 Clinical and EEG data of adult-onset autosomal d
Patients IQ Epileps
Pedigree
reference
Age
(years)
FSIQa VIQb PIQc Age at
onset
(years)
II-1 68 96 95 99 38
II-3 59 90 89 95 35
II-4 56 99 98 101 42
II-5 51 101 102 99 40
III-3 45 NAg NA NA 38
III-4 41 NA NA NA 37
III-5 39 NA NA NA 38
III-10 37 104 102 98 36
III-14 36 NA NA NA 35
The routine scalp EEG from proband III-1, III-2, III-9, III-11, IV-1, an
a FSIQ: full-scale IQ.
b VIQ: verbal IQ.
c PIQ: performance IQ.
d SW: spike-and-waves.
e PSW: polyspike-and-waves.
f GTC: generalized tonic-clonic seizure.
g NA: not available.
h Proband III-5 has clonazepam 0.5 mg per night.Discussion
In this presentation of non-progressive, adult-onset,
autosomal dominant myoclonic epilepsy in a four-
generation family in East Taiwan, we could not
provide a recognized syndromic diagnosis for some
of the clinical features.
Primary IGE is commonly thought to arise in child-
hood or adolescence, but Gastaut reported a high
prevalence of adult-onset IGE (in up to 35% of
patients) in 1981.3 In 2003, Marini et al. identified
121 patients with IGE in whom 34 had seizures that
started at the age of 20 years or thereafter, with 5 of
the 34 patients commencing seizures after the age
of 40. Adult-onset IGE also had common clinical
features: generalized spike/polyspike-and-wave
EEG activities, good antiepileptic drug response,
favorable prognosis, probable genetic basis, and
normal brain.4 These cardinal features are not pro-
minently different from JME or our affected family
members.
Juvenile myoclonic epilepsy is a common form of
IGE representing 5—10% of all epilepsy cases.6
Approximately, 17—50% of patients have a family
history of epilepsy.7 Individuals most commonly pre-
sent between the ages of 8 and 26 with myoclonus.
The myoclonus is characterized by early morning
attack and symmetric jerks of the upper limbs, as
well as precipitated by fatigue, alcohol, and men-
struation. Over 90% also have generalized tonic-clo-
nic seizures, and 30% experience absence seizures.
The response toanti-convulsantmonotherapy suchasominant myoclonic epilepsy kindred
y
Type of
seizures
Epileptiform
EEG
discharges
Dosage of
valproic
acid (mg/day)
Myoclonic SWd 200
Myoclonic SW, PSWe 200
Myoclonic SW 200
Myoclonic, GTCf SW, PSW 200
Myoclonic, GTC SW, PSW 500
Myoclonic SW 200
Myoclonic SW, PSW 0.5h
Myoclonic SW 200
Myoclonic SW 200
d IV-2 did not detect any abnormal EEG activity.
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after the discontinuation of medication.8 In our
affected individuals, the age of seizure onset was
greater than in JME patients. The affected probands
did not experience photosensitivity. Episodes ofmyo-
clonic jerks would occur in almost all behavioral
states. These clinical features were distinguishable
from JME.
It is well established that hereditary contributes
the etiology of JME. Cossette et al. reported an
interesting finding in the area of JME genetics.5
An Ala322Asp mutation in the GABRA1 gene that
codes for the a1 subunit of the g-aminobutyric acid
receptor subtype A (GABAA) was found in the
affected members of a large French-Canadian
family exhibiting the autosomal dominant form of
JME. This mutation in GABRA1 is the first known
mutation that segregates with the classical JME
clinical phenotype. All affected individuals in this
family were heterozygous for a C! A substitution in
exon 9 of GABRA1, which is predicted to change a
GCC (alanine) to a GAC (aspartic acid) codon at
position 322 of its cDNA. Each affected family mem-
ber presented similar clinical features, with myo-
clonus and GTCs. Some of them also presented
absence seizures. The EEG abnormalities found in
affected members of the family showed generalized
polyspike-and-wave epileptic discharges, which
would occur spontaneously or be precipitated by
photic stimulation. The mean age of onset was 11.8
years. Our affected family members had myoclonic
seizures at a mean age of 37.5 years. Although
GABRA1 Ala322Asp mutation contributed to the
generation of myoclonic seizures, we did not
observe this in our affected individuals. Shaochun
et al. and Kapoor et al. systemically screened the
Ala322Asp mutation in JME families with exhibiting
dominant inheritance from Europe and India,
respectively.9,10 This mutation did not appear.
Two recently reported myoclonic epileptic
syndromes, benign familial autosominal dominant
myoclonic epilepsy and autosomal dominant corti-
cal reflex myoclonus and epilepsy, share similar
characteristics, including autosomal dominant
heritance, adult-onset, non-progressive course,
cortical myoclonus, generalized seizures, and giant
SEP.11—13 However, our patients did not have cortical
tremors, a photoparoxysmal response, or giant scalp
SEPs.
Actually, the clinical and EEG features of our
affected members resembled patients in the study
by Marini et al., who are described as ‘‘adult onset
myoclonic epilepsy’’.4 Marini and colleagues cate-
gorized six patients into the ‘‘subsyndrome’’. These
patients presented withmyoclonic jerks and GTCs at
a mean onset age of 37. The seizures and EEG ofanother case of a 75-year-old woman in the same
study were strikingly similar. She had dominant jerks
of the upper limbs, and generalized polyspike-wave
of EEG activity. Only two probands of our patients
had a history of GTCs. They were not supposed to
have absences. However, no member of the fourth
generation had myoclonic seizure. We assume that
the onset age does not achieve. We expect to find
new affected members in the fourth generation in
the coming decade.Conclusion
Work on the classification of epileptic syndromes is
ongoing. Many syndromes are still under discussion.
The non-progressive, adult-onset, autosomal domi-
nant myoclonic epilepsy described here appears to
have remarkable features that clearly distinguish
the condition from other recognized myoclonic epi-
lepsies. The epileptic syndrome may be a variant of
JME or a variety of subsyndrome. Genetic analysis
should help to clarify the etiology and pathophysiol-
ogy of this myoclonic epilepsy.Acknowledgements
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